ACUMEDIUM SIGNALOPPORTUNITY10-K

ACU demonstrates strong operational performance with significant operating cash flow growth (+52%) and successful acquisitions in Germany and medical products, though capital deployment reduced cash reserves.

The company shows healthy execution with diversified growth through strategic acquisitions and improved cash generation efficiency. However, the substantial cash decline (-44%) following increased capital expenditures and acquisitions requires monitoring to ensure adequate liquidity for future operations and growth investments.

Comparing 2026-03-11 vs 2025-03-06View on EDGAR →
FINANCIAL ANALYSIS

ACU delivered strong operational performance with operating cash flow surging 52% to $18.2M, while simultaneously investing heavily in growth through 49% higher capital expenditures ($10.7M) and strategic acquisitions. The company's cash position declined significantly by 44% to $3.6M, reflecting aggressive capital deployment, though the dramatic improvement in cash generation suggests the business fundamentals are strengthening. The 58% reduction in R&D expenses may indicate either operational efficiency gains or potential future innovation constraints that warrant monitoring.

FINANCIAL STATEMENT CHANGES
R&D Expense
P&L
-57.9%
$596K→$251K

R&D spending cut 57.9% — could signal cost discipline or concerning reduction in innovation investment.

Operating Cash Flow
Cash Flow
+52.2%
$12.0M→$18.2M

Operating cash flow surged 52.2% — exceptional cash generation, highest quality earnings signal.

Capital Expenditure
Cash Flow
+49%
$7.1M→$10.7M

Capital expenditure jumped 49% — major investment cycle underway; assess returns on deployment.

Cash & Equivalents
Balance Sheet
-43.8%
$6.4M→$3.6M

Cash declined 43.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

LANGUAGE CHANGES
NEW — 2026-03-11
PRIOR — 2025-03-06
ADDED
Registrant had 3,808,225 shares of its $2.50 par value Common Stock outstanding as of March 6, 2026.
Recent Accomplishments and Initiatives Quantitative Achievements In 2025, the Company s key financial accomplishments included the following: Sales Growth Average annual growth rate over eleven years of 7%.
Dividend Increase - Increase in the quarterly dividend from $.02 per share in 2004 to $.16 per share in 2025 an eight-fold increase.
Business and Operational Milestones and Achievements Diversification of Product Lines During the past nine years, sales of first aid and medical products have grown to approximately 66% of total sales.
3 Cutting Acquisition On October 1, 2025, the Company acquired a line of cutting and sharpening tools in Germany with annual revenue of approximately $2 million.
First Aid Acquisition In 2025, the Company successfully negotiated the acquisition of the assets of My Medic.
My Medic is a leading supplier of tactical, trauma and emergency response products with annual revenue of approximately $19 million.
Product Innovation In 2025, we introduced new first aid bar code scanning technology that expedites replenishment, ensuring OSHA compliance.
Cost Reduction Initiatives In 2025, the Company invested in robotics in three of its manufacturing and distribution facilities which has already improved productivity.
Additionally, the Company invested in equipment to automate its Spill Magic powder manufacturing process; the project is expected to be completed in 2026.
REMOVED
Registrant had 3,754,498 shares of its $2.50 par value Common Stock outstanding as of February 28, 2025.
The components for the first aid kits are sourced from both U.S.
Recent Accomplishments and Initiatives Quantitative Achievements In 2024, the Company s key financial accomplishments included the following: Sales Growth Continued strong average annual growth rate, 7% over ten years (2015 - 2024).
Dividend Increase - Increase in the quarterly dividend from $.02 per share in 2004 to $.15 per share in 2024 an eight-fold increase.
Business and Operational Milestones and Achievements 3 Diversification of Product Lines During the past eight years, sales of first aid and medical products have grown to approximately 61% of total sales.
In addition, our sales of school, home, craft and office products increased 10% in 2024, partly due to the introduction of new products.
First Aid Acquisition On May 23, 2024, the Company acquired the assets of Elite First Aid, Inc., a leading supplier of tactical, trauma and emergency response products.
The Company successfully completed the integration of the assets and business in the fourth quarter of 2024.
Markets/Products In 2024 we: Introduced first aid SmartCabinet 2.0 with patented RFID technology that automates the requisition process and helps end users to maintain OSHA compliance.
Expanded in the craft market by providing advanced cutting tools which are used to create precise and unique designs.
MORE OPPORTUNITY SIGNALS
ABTHIGHAbbott announced a major strategic acquisition of Exact Sciences Corporation to ...
2026-02-20
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →